DOCSLIB.ORG

Succinate Receptors in the Kidney

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Succinate Receptors in the Kidney BRIEF REVIEW www.jasn.org Succinate Receptors in the Kidney Peter M.T. Deen and Joris H. Robben Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands ABSTRACT The G protein–coupled succinate and ␣-ketoglutarate receptors are closely related to nyl-CoA synthetase and subsequently the family of P2Y purinoreceptors. Although the ␣-ketoglutarate receptor is almost converted by succinate dehydrogenase exclusively expressed in the kidney, its function is unknown. In contrast, the succinate to generate fumarate. Because the suc- receptor, SUCRN1, is expressed in a variety of tissues, including blood cells, adipose cinate dehydrogenase complex is part of the tissue, liver, retina, and the kidney. Recent evidence suggests SUCRN1 and its succi- electron transport chain in the mitochon- nate ligand are novel detectors of local stress, including ischemia, hypoxia, toxicity, drial membrane (complex II; Figure 2), its and hyperglycemia. Local levels of succinate in the kidney also activate the renin- activity indirectly depends on the avail- angiotensin system and together with SUCRN1 may play a key role in the develop- ability of oxygen. As such, in situations ment of hypertension and the complications of diabetes mellitus, metabolic disease, when oxygen tension is low, succinate and liver damage. This makes the succinate receptor a promising drug target to accumulates because of low activity of counteract an expanding number of interrelated disorders. succinate dehydrogenase or other en- zymes in the electron transport chain J Am Soc Nephrol 22: 1416–1422, 2011. doi: 10.1681/ASN.2010050481 that affect its activity.5–7 Low oxygen states, such as ischemia8 or exercise9 also increase circulating levels of succinate. G protein–coupled receptors (GPCRs) are ever, GPR91 and GPR99 activate specifi- The effect of low oxygen states on suc- proteins in the plasma membrane harbor- cally through the Krebs cycle intermediates cinate levels is also obvious in rats ␣ ing seven transmembrane spanning do- succinate and -ketoglutarate (also called anesthetized with 100% CO2 instead of mains. They are activated by a wide variety oxoglutarate), respectively.3 There- oxygenated isoflurane; succinate levels of moieties including peptides, lipids, pu- fore, the gene encoding GPR91 was re- increased from 7 to 40 ␮M in the left rines, chemokines, odorants, and light. named SUCNR1 (succinate receptor 1), ventricle and up to 173 ␮M from low- Based on sequence homology to known re- whereas the gene encoding GPR99 was re- oxygen blood collected from the vena ceptors, the sequencing of the human ge- named OXGR1 (for oxoglutarate receptor 1). cava.10 nome accelerated the identification of The tissue distribution of SUCRN1 and Alternatively, other changes in energy many novel GPCRs, now numbering OXGR1 are highly expressed in the kidney.3,4 balance affect the production and release Ͼ800 family members. Many of these Although mRNA encoding OXGR1 is de- of succinate, particularly in animal mod- novel receptors have no known ligands and tected in the renal distal convoluted and con- els of diabetes mellitus,11 metabolic dis- therefore are known as orphan GPCRs. necting tubule, no function is known as yet. ease,10 and liver damage.12 During chronic In 2001, a cluster of six GPCRs was Several physiologic roles SUCNR1 have hyperglycemia, the high activity of the identified on chromosome 3q24–3q25, in- emerged, and we will focus here on its signal- Krebs cycle increases the Hϩ gradient cluding the four orphan receptors GPR86, ing in the kidney and its involvement in the across the mitochondrial membrane (Fig- GPR87, H963, and GPR91.1 The latter development of hypertension in diabetes shares high sequence homology with the mellitus. Published online ahead of print. Publication date family of P2Y purinoreceptors. Shortly available at www.jasn.org. thereafter, another novel receptor of this Correspondence: Dr. J. H. Robben, 286 Department subfamily was identified on chromosome REGULATION OF SUCCINATE of Physiology, Nijmegen Centre for Molecular Life Sci- 13q32.2, GPR99,2 showing high sequence LEVELS ences, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands. Phone: 31- homology with GPR91 and P2Y receptors 2436-13684; Fax: 31-2436-16413; E-mail: j.robben@ (Figure 1). Thus, GPR91 and GPR99 might Succinate is a well-known intermediate in fysiol.umcn.nl be expected to activate on contact with pu- the tricarboxylic acid (Krebs) cycle, where Copyright © 2011 by the American Society of rinergic compounds. Surprisingly, how- it is formed from succinyl-CoA by succi- Nephrology 1416 ISSN : 1046-6673/2208-1416 J Am Soc Nephrol 22: 1416–1422, 2011 www.jasn.org BRIEF REVIEW P2Y12 P2Y13 Outer membrane P2Y14 ATP P2Y10 synthase H+ H+ H+ P2Y5 Cyt c P2Y8 P P2Y11 I III IV II OXGR1 SUCNR1 P2Y1 + + ADP H ATP NAD NADH O2 H2O P2Y2 + + Pi H+ P2Y4 P2Y6 Citric acid Figure 1. Phylogenetic tree of the family cycle of P2Y purinergic receptors. Amino acid sequences encoding human P2Y receptors H OO Fumarate Succinate were aligned, resulting in a phylogenetic 2 2 tree based on closest sequence homology. II ure 2), inhibiting individual complexes of IV IIIP I Inner membrane the electron transport chain including suc- 6 Cyt c cinate dehydrogenase. This results in the H+ H+ H+ intracellular accumulation and eventually release of succinate. Figure 2. Generation of succinate in mitochondria. Succinate is an intermediate in the SUCNR1 IS A LOCAL SENSOR OF citric acid cycle and is converted by succinate dehydrogenase (also called complex II) to ϩ STRESS fumarate. When high H gradients over the inner membrane are present, or when the oxygen pressure is low, complexes I, II, III, and IV will be inhibited, leading to accumu- Quantitative PCR assays show mRNA lation of succinate. See text for more details. encoding SUCNR1 in kidney, liver, and spleen,3 and a subsequent study con- adenylate cyclase to form cAMP.4 Be- idly,12,13 suggesting that SUCNR1 serves firmed its expression in kidney and liver, cause increased succinate levels are found as an early detector of hepatic stress or as well as in white adipose tissue.4 Subse- in rodent models of diabetes mellitus and damage. Application of ischemia in a quently, several studies described the metabolic syndrome,10,11 high succinate perfused liver model increases succinate function of SUCNR1 in specific cell types levels may prevent lipolysis in states when levels of the perfusate 14-fold to approx- in these tissues. Although its detailed fuels such as glucose and free fatty acids are imately 1 mM.12 Moreover, HSCs treated function remains to be established in abundant. with succinate show increased levels of a most settings, it is clear this receptor is a myofibroblastic marker compared with detector of disturbances in energy bal- Stellate Cell Activation in Liver inactive control cells, indicating that suc- ance. Pathology cinate independently stimulates HSC ac- The liver is crucial for regulating the tivation. SUCNR1 signaling, therefore, Regulation of Lipolysis in White body’s metabolism by storing fuel mole- plays a role in HSC activation to restore Adipose Tissue cules such as glycogen and plays a major damaged tissue in the ischemic liver or In states of hypoglycemia, hormones role in lipid and amino acid conversion contributes to the formation of fibrosis. such as glucagon trigger adipocytes in or synthesis, as well as the degradation of The signaling pathways involved in white adipose tissue to degrade triglycer- toxic compounds. Likely, therefore, this this HSC activation remain obscure. In ides into free fatty acids for energy pro- organ is subject to multiple stressors pri- contrast to adipocytes or renal cells (see duction. Stimulatory Gs proteins medi- marily related to an unhealthy lifestyle. below), administration of succinate to ate this process of lipolysis. In SUCNR1ϩ In the liver, SUCNR1 is exclusively ex- HSCs fails to induce an intracellular adipocytes, succinate inhibits lipolysis in pressed in quiescent hepatic stellate cells Ca2ϩ response, nor does it decrease for- a pertussis toxin–dependent manner, (HSCs), but on activation of HSCs, the skolin-induced cAMP levels or increase showing that SUCNR1 signaling inhibits expression of SUCNR1 decreases rap- cAMP levels by itself.12 For comparison, J Am Soc Nephrol 22: 1416–1422, 2011 Clinical Potential of SUCNR1 1417 BRIEF REVIEW www.jasn.org the downstream effectors of SUCNR1 pared with controls.16 This suggests a downregulates SUCNR1 expression when signaling in different tissues and cell role for succinate in atherothrombosis, DCs achieve maturity. Furthermore, un- types are summarized in Table 1. in which succinate levels may increase derscoring the fact that the above observa- because of local hypoxia. tions are SUNCR1-mediated, mice chal- Apoptosis of Cardiomyocytes In hematopoietic progenitor cells, ac- lenged with tetanus toxin accumulate 14 A recent study by Aguiar et al. showed the tivated SUCNR1 signals through Gi/o higher levels of mature DCs in their lymph presence of mRNA encoding SUCNR1 and proteins to induce cell proliferation via nodes compared with SUCNR1Ϫ/Ϫ mice. protein in freshly isolated preparations of extracellular regulated kinases (ERK)1 Grafts from SUCNR1Ϫ/Ϫ mice show im- ventricular cardiomyocytes, where it local- and 2. Also, SUCNR1 activation protects proved outcome during skin graft rejec- izes in the sarcolemmal membrane and T- the erythroleukemic cell line, TF1, from se- tion.17 As such, interfering with SUCNR1 tubules. In these cardiomyocytes, succi- rum starvation-induced apoptosis. To- signaling by specific receptor antagonists nate leads to increased protein kinase A gether, this explains how administration of or preventing succinate accumulation may activity that subsequently releases intracel- succinate in a mouse model of chemother- be beneficial for patients receiving organ lular calcium transients. Moreover, succi- apy-induced myelosuppression leads to in- transplants. However, specific inhibitors of nate-stimulated cardiomyocytes show in- creased levels of hemoglobin, platelets, and the SUCNR1 remain to be developed.
Load more

Recommended publications
  • Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-Helminth Immunity in the Small Intestine but Are Dispensable for Anti-Protist Immunity
    Article Tuft-Cell-Derived Leukotrienes Drive Rapid Anti- helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity Graphical Abstract Authors John W. McGinty, Hung-An Ting, Tyler E. Billipp, ..., Hong-Erh Liang, Ichiro Matsumoto, Jakob von Moltke Correspondence [email protected] In Brief Tuft cells regulate type 2 immunity in the small intestine by secreting the cytokine IL-25. McGinty et al. identify cysteinyl leukotriene production as an additional tuft cell effector function. Tuft-cell- derived leukotrienes drive anti-helminth immunity in the intestine but are dispensable for the response induced by tritrichomonad protists. Highlights d Cysteinyl leukotrienes activate intestinal ILC2s d Cysteinyl leukotrienes drive rapid anti-helminth type 2 immune responses d Tuft cells are the source of cysteinyl leukotrienes during helminth infection d Tuft-cell-derived leukotrienes are not required for the anti- protist response McGinty et al., 2020, Immunity 52, 528–541 March 17, 2020 ª 2020 Elsevier Inc. https://doi.org/10.1016/j.immuni.2020.02.005 Immunity Article Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity John W. McGinty,1 Hung-An Ting,1 Tyler E. Billipp,1 Marija S. Nadjsombati,1 Danish M. Khan,1 Nora A. Barrett,2 Hong-Erh Liang,3,4 Ichiro Matsumoto,5 and Jakob von Moltke1,6,* 1Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA 2Division of Rheumatology, Immunology and Allergy, Jeff
    [Show full text]
  • Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)
    BRIEF COMMUNICATION www.jasn.org Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron Camille Ansermet,* Matthias B. Moor,* Gabriel Centeno,* Muriel Auberson,* † † ‡ Dorothy Zhang Hu, Roland Baron, Svetlana Nikolaeva,* Barbara Haenzi,* | Natalya Katanaeva,* Ivan Gautschi,* Vladimir Katanaev,*§ Samuel Rotman, Robert Koesters,¶ †† Laurent Schild,* Sylvain Pradervand,** Olivier Bonny,* and Dmitri Firsov* BRIEF COMMUNICATION *Department of Pharmacology and Toxicology and **Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland; †Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; ‡Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia; §School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia; |Services of Pathology and ††Nephrology, Department of Medicine, University Hospital of Lausanne, Lausanne, Switzerland; and ¶Université Pierre et Marie Curie, Paris, France ABSTRACT Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is crit- leaves.4 Most recently, Legati et al. have ical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the shown an association between genetic kidney glomerulus and is reabsorbed in the renal tubule by the action of the apical polymorphisms in Xpr1 and primary fa- sodium-dependent phosphate transporters, NaPi-IIa/NaPi-IIc/Pit2. However, the milial brain calcification disorder.5 How- molecular identity of the protein(s) participating in the basolateral Pi efflux remains ever, the role of XPR1 in the maintenance unknown. Evidence has suggested that xenotropic and polytropic retroviral recep- of Pi homeostasis remains unknown. Here, tor 1 (XPR1) might be involved in this process. Here, we show that conditional in- we addressed this issue in mice deficient for activation of Xpr1 in the renal tubule in mice resulted in impaired renal Pi Xpr1 in the nephron.
    [Show full text]
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Bioinformatics Method Identifies Potential Biomarkers of Dilated Cardiomyopathy in a Human Induced Pluripotent Stem Cell‑Derived Cardiomyocyte Model
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 14: 2771-2778, 2017 Bioinformatics method identifies potential biomarkers of dilated cardiomyopathy in a human induced pluripotent stem cell‑derived cardiomyocyte model YU ZHUANG1, YU-JIA GONG2, BEI-FEN ZHONG3, YI ZHOU1 and LI GONG4 1Department of Cardiovascular Surgery, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080; 2Stomatology Faculty, School of Medicine, Nantong University, Nantong, Jiangsu 226000; 3Department of Urology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080; 4Department of Cardiothoracic Surgery, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu 223002, P.R. China Received February 19, 2016; Accepted February 10, 2017 DOI: 10.3892/etm.2017.4850 Abstract. Dilated cardiomyopathy (DCM) is the most common crucial nodes in module 2, which were linked to each other. type of cardiomyopathy that account for the majority of heart In conclusion, several potential biomarkers for DCM were failure cases. The present study aimed to reveal the under- identified, such as MMP2, FLT1, CDH1, ITGB6, COL6A3, lying molecular mechanisms of DCM and provide potential COL6A1, LAMC2, PENK and APLNR. These genes may serve biomarkers for detection of this condition. The public dataset significant roles in DCM via involvement of various BPs, such of GSE35108 was downloaded, and 4 normal induced pluripo- as blood vessel and vasculature development and cell adhe- tent stem cell (iPSC)-derived cardiomyocytes (N samples) and sion, and the ECM-receptor interaction pathway. 4 DCM iPSC-derived cardiomyocytes (DCM samples) were utilized. Raw data were preprocessed, followed by identifica- Introduction tion of differentially expressed genes (DEGs) between N and DCM samples.
    [Show full text]
  • G Protein-Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]
  • Cell Differentiation Is Disrupted by MYO5B Loss Through Wnt/Notch Imbalance
    Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance Izumi Kaji, … , Masahiko Watanabe, James R. Goldenring JCI Insight. 2021;6(16):e150416. https://doi.org/10.1172/jci.insight.150416. Research Article Gastroenterology Functional loss of myosin Vb (MYO5B) induces a variety of deficits in intestinal epithelial cell function and causes a congenital diarrheal disorder, microvillus inclusion disease (MVID). The impact of MYO5B loss on differentiated cell lineage choice has not been investigated. We quantified the populations of differentiated epithelial cells in tamoxifen- induced, epithelial cell–specific MYO5B-knockout (VilCreERT2 Myo5bfl/fl) mice utilizing digital image analysis. Consistent with our RNA-sequencing data, MYO5B loss induced a reduction in tuft cells in vivo and in organoid cultures. Paneth cells were significantly increased by MYO5B deficiency along with expansion of the progenitor cell zone. We further investigated the effect of lysophosphatidic acid (LPA) signaling on epithelial cell differentiation. Intraperitoneal LPA significantly increased tuft cell populations in both control and MYO5B-knockout mice. Transcripts for Wnt ligands were significantly downregulated by MYO5B loss in intestinal epithelial cells, whereas Notch signaling molecules were unchanged. Additionally, treatment with the Notch inhibitor dibenzazepine (DBZ) restored the populations of secretory cells, suggesting that the Notch pathway is maintained in MYO5B-deficient intestine. MYO5B loss likely impairs progenitor cell differentiation in the small intestine in vivo and in vitro, partially mediated by Wnt/Notch imbalance. Notch inhibition and/or LPA treatment may represent an effective therapeutic approach for treatment of MVID. Find the latest version: https://jci.me/150416/pdf RESEARCH ARTICLE Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance Izumi Kaji,1,2 Joseph T.
    [Show full text]
  • Receptor Structure-Based Discovery of Non-Metabolite Agonists for the Succinate Receptor GPR91
    Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91 Trauelsen, Mette; Rexen Ulven, Elisabeth; Hjorth, Siv A; Brvar, Matjaz; Monaco, Claudia; Frimurer, Thomas M; Schwartz, Thue W Published in: Molecular Metabolism DOI: 10.1016/j.molmet.2017.09.005 Publication date: 2017 Document version Publisher's PDF, also known as Version of record Document license: CC BY-NC-ND Citation for published version (APA): Trauelsen, M., Rexen Ulven, E., Hjorth, S. A., Brvar, M., Monaco, C., Frimurer, T. M., & Schwartz, T. W. (2017). Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91. Molecular Metabolism, 6(12), 1585-1596. https://doi.org/10.1016/j.molmet.2017.09.005 Download date: 08. apr.. 2020 Original Article Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91 Mette Trauelsen 1, Elisabeth Rexen Ulven 3, Siv A. Hjorth 2, Matjaz Brvar 3, Claudia Monaco 4, Thomas M. Frimurer 1,*, Thue W. Schwartz 1,2,* ABSTRACT Objective: Besides functioning as an intracellular metabolite, succinate acts as a stress-induced extracellular signal through activation of GPR91 (SUCNR1) for which we lack suitable pharmacological tools. Methods and results: Here we first determined that the cis conformation of the succinate backbone is preferred and that certain backbone modifications are allowed for GPR91 activation. Through receptor modeling over the X-ray structure of the closely related P2Y1 receptor, we discovered that the binding pocket is partly occupied by a segment of an extracellular loop and that succinate therefore binds in a very different mode than generally believed.
    [Show full text]
  • Downloaded on 27 May 2020
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.07.438755; this version posted April 7, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title: Cells of the human intestinal tract mapped across space and time Elmentaite R1, Kumasaka N1, King HW2, Roberts K1, Dabrowska M1, Pritchard S1, Bolt L1, Vieira SF1, Mamanova L1, Huang N1, Goh Kai’En I3, Stephenson E3, Engelbert J3, Botting RA3, Fleming A1,4, Dann E1, Lisgo SN3, Katan M7, Leonard S1, Oliver TRW1,8, Hook CE8, Nayak K10, Perrone F10, Campos LS1, Dominguez-Conde C1, Polanski K1, Van Dongen S1, Patel M1, Morgan MD5,6, Marioni JC1,5,6, Bayraktar OA1, Meyer KB1, Zilbauer M9,10,11, Uhlig H12,13,14, Clatworthy MR1,4, Mahbubani KT15, Saeb Parsy K15, Haniffa M1,3, James KR1* & Teichmann SA1,16* Affiliations: 1. Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK. 2. Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London E1 2AT, UK 3. Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. 4. Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK 5. European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK. 6. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK 7. Structural and Molecular Biology, Division of Biosciences, University College London WC1E 6BT, UK 8.
    [Show full text]
  • Activation of Intestinal Tuft Cell-Expressed Sucnr1 Triggers Type 2 Immunity in the Mouse Small Intestine
    Activation of intestinal tuft cell-expressed Sucnr1 triggers type 2 immunity in the mouse small intestine Weiwei Leia,1, Wenwen Rena,1, Makoto Ohmotoa, Joseph F. Urban Jr.b, Ichiro Matsumotoa, Robert F. Margolskeea, and Peihua Jianga,2 aMonell Chemical Senses Center, Philadelphia, PA 19104; and bDiet, Genomics and Immunology Laboratory, Beltsville Human Nutrition Research Center, Agricultural Research Service, US Department of Agriculture, Beltsville, MD 20705 Edited by Robert J. Lefkowitz, Howard Hughes Medical Institute and Duke University Medical Center, Durham, NC, and approved April 19, 2018 (received for review November 28, 2017) The hallmark features of type 2 mucosal immunity include in- Expulsion of the intestinal worm parasite Nippostrongylus brasi- − − testinal tuft and goblet cell expansion initiated by tuft cell liensis from the gut is significantly delayed in Pou2f3 / mice activation. How infectious agents that induce type 2 mucosal compared with wild-type mice (8). The current model suggests tuft immunity are detected by tuft cells is unknown. Published micro- cells detect parasitic infection via taste-signaling elements and se- array analysis suggested that succinate receptor 1 (Sucnr1) is spe- crete the proinflammatory cytokine IL-25, which subsequently cifically expressed in tuft cells. Thus, we hypothesized that the triggers mucosal type 2 responses via IL-13–producing ILC2s and succinate–Sucnr1 axis may be utilized by tuft cells to detect certain IL-13 receptor alpha-expressing intestinal epithelial progenitor cells
    [Show full text]
  • Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Amy Sue Bogard University of Tennessee Health Science Center
    University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 12-2013 Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Amy Sue Bogard University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Medical Cell Biology Commons, and the Medical Molecular Biology Commons Recommended Citation Bogard, Amy Sue , "Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells" (2013). Theses and Dissertations (ETD). Paper 330. http://dx.doi.org/10.21007/etd.cghs.2013.0029. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Biomedical Sciences Track Molecular Therapeutics and Cell Signaling Research Advisor Rennolds Ostrom, Ph.D. Committee Elizabeth Fitzpatrick, Ph.D. Edwards Park, Ph.D. Steven Tavalin, Ph.D. Christopher Waters, Ph.D. DOI 10.21007/etd.cghs.2013.0029 Comments Six month embargo expired June 2014 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/330 Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Amy Sue Bogard December 2013 Copyright © 2013 by Amy Sue Bogard.
    [Show full text]